A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT03866967 · COMPLETED
Trial details
- NCT number
- NCT03866967
- Sponsor
- Akeso
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-27
- Primary completion
- 2021-03-13
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.